Eplerenone is a medication that belongs to the class of mineralocorticoid receptor antagonists and acts by selectively blocking aldosterone mediated sodium retention. It is used therapeutically to manage hypertension and heart failure by reducing fluid accumulation and lowering blood pressure. The active ingredient works by binding to the mineralocorticoid receptor in renal epithelial cells, preventing aldosterone from stimulating sodium reabsorption and potassium excretion. This antagonism leads to increased sodium and water excretion, decreased blood volume, and consequently reduced cardiac workload. The resulting physiological effect includes lower peripheral vascular resistance and improved cardiac output in patients with heart failure. By attenuating aldosterone driven pathways the drug helps to preserve potassium levels while promoting diuresis. It does not directly affect the sympathetic nervous system but indirect hemodynamics improve as fluid overload diminishes. Overall Eplerenone provides a targeted approach to modulate renin angiotensin aldosterone system activity without the broad side effects associated with older agents.

Eplerenone is a selective aldosterone antagonist used primarily for the treatment of hypertension. It works by blocking the binding of aldosterone to mineralocorticoid receptors in the distal nephron. This blockade prevents sodium reabsorption and potassium retention in the kidneys. As a result the body excretes more sodium and water, which reduces blood volume. The decrease in blood volume leads to a lowering of systemic vascular resistance. The medication also mitigates the effects of aldosterone mediated processes such as potassium uptake and hydrogen ion excretion. Through these actions Eplerenone helps maintain electrolyte balance while supporting cardiovascular homeostasis. Its specificity for the mineralocorticoid receptor over the progesterone receptor minimizes off target interactions.

Eplerenone may cause dizziness or lightheadedness, especially after the first doses. It can also lead to headache or fatigue in some patients. Some individuals experience elevated potassium levels that may cause muscle weakness. Swelling of the ankles or feet can occur as a sign of fluid retention. The medication sometimes results in a dry cough or sore throat. Skin rash or itching may develop as an allergic reaction. Rarely, it can cause changes in taste or nausea. Most side effects are mild and often improve with continued use.

Eplerenone may cause dizziness or lightheadedness especially when standing up quickly. Some people experience mild fatigue or weakness during treatment. Headaches are reported by a minority of users. Elevated potassium levels can occur, leading to symptoms such as muscle weakness or irregular heartbeat. Skin reactions like rash or itching may develop in rare cases. Gastrointestinal discomfort including nausea or abdominal pain has been noted. Swelling of the feet or ankles can happen due to fluid retention.